:To contribute and manage a translational clinical program in cancer immunotherapy, with emphasis on cancer vaccines and Immunomodulators in combination with cancer vaccines. The primary goal of this clinical program is to translate the findings of hypothesis-driven preclinical studies to the design and implementation of collaborative clinical trials. Clinical trials will be conducted employing cancer vaccines mainly in combination with other novel and conventional therapies in patients with col...
